When a Hair Transplant Is the Wrong Answer, and Why a Clinic Should Say So

Almost every clinic page answers "am I a candidate?" with a version of yes. The consultation is often the sales appointment, and the commercial pressure runs in one direction only. So a page setting out the reasons you might be turned away is unusual, and worth reading with that in mind.

None of what follows is a policy invented in an office. Each item is a clinical finding that changes what surgery can do, and in several cases makes it actively harmful. The useful framing is not who gets rejected, but which diagnosis sits underneath the hair loss and whether moving hair around solves it.

What a transplant can and cannot do

A transplant moves existing hair from the back and sides of the scalp to the top. It does not create hair, it does not stop the process that took the hair away, and it cannot increase your total number of follicles. Every reason for declining someone follows from those three facts.

If the donor supply is itself diseased, there is nothing safe to move. If the loss is still advancing quickly, transplanted hair is left stranded as the area around it thins. If the cause is a treatable illness, surgery addresses the symptom and ignores the disease. And if the distress is not really about density, no surgical result settles it.

Diffuse unpatterned alopecia, and why it rules surgery out

Ordinary male pattern loss is androgen-driven and spares a band at the back and sides — that band is the whole basis of transplant surgery (DermNet on androgenetic alopecia). Diffuse unpatterned alopecia, usually shortened to DUPA, is the version where that sparing does not happen. The thinning runs across the whole scalp, including the donor zone.

Under magnification the donor area in DUPA shows widespread miniaturisation — hairs of noticeably different calibres side by side, rather than the uniform thick shafts a healthy donor zone shows. That finding decides it, and it is invisible to the naked eye and to a photograph sent over WhatsApp.

Grafts taken from a miniaturising donor area carry the miniaturisation with them. You would be moving hair that is on its way out, thinning the back where extraction happened and gaining very little at the front. Understanding what a donor area can safely supply is the most important part of assessment, and DUPA is the case where the answer is that it can supply nothing.

Rapid loss in the early twenties

Age alone does not disqualify anyone. An unstable pattern does. A man of twenty-two who has moved noticeably in eighteen months is telling you the process is running fast, and nobody can predict where it stops.

Operate into that, and the arithmetic goes wrong twice. The hairline gets placed where a twenty-two-year-old wants it, low and straight, which is a position a forty-year-old face does not carry well. And the native hair behind it keeps disappearing, so within a few years there is a transplanted strip with a bald gap behind it, and the donor supply has been partly spent on a problem that had not finished happening. Where you sit on the Norwood scale matters far less here than whether that position has changed in two years.

The right response is not "come back when you are thirty". It is medical treatment aimed at slowing the process, photographs at fixed angles, and a review in six to twelve months. How minoxidil and finasteride are actually used matters more in this group than any other, because they act on the mechanism surgery cannot touch.

Diffuse thinning where there is no bald area to fill

This is the commonest reason a woman is declined, and it applies to plenty of men too. If the whole top of the scalp is thinner rather than bare in a defined shape, there is no donor-to-recipient gradient to exploit. Coverage is made by taking density from an area that has plenty and giving it to one that has none. Where no area has plenty, the transaction produces no visible gain.

Worse, extraction from a diffusely thinned donor zone can make the back of the head look worse while the front barely changes. In practice this is the group where an honest assessment of how female pattern loss is graded and treated leads somewhere quite different from surgery, and usually somewhere better.

Untreated medical causes that come first

Some people who arrive asking about surgery do not have pattern loss at all, or have it alongside something else doing most of the visible damage. Thyroid disease, iron deficiency, recent illness, crash dieting, post-partum shedding and some medications all cause hair loss that behaves differently, and much of it reverses when the cause is addressed (NHS on hair loss).

The clue is usually the pattern of shedding rather than the pattern of baldness — hair coming out over the whole scalp, often weeks after a trigger, is telogen effluvium rather than genetic loss. Telling shedding apart from pattern balding is the first fork in the road, and getting it wrong sends someone to theatre for a problem that correcting a ferritin level would have improved. The blood tests genuinely worth doing are few, cheap, and occasionally change everything.

Active alopecia areata, scarring alopecias and inflamed scalps

Alopecia areata

This is autoimmune, patchy, and can regrow on its own or with treatment. Transplanting into an active area is futile, because the same immune process that attacked the native follicles attacks the transplanted ones. Surgery is only ever discussed in long-quiescent, stable disease, and even then cautiously (DermNet on alopecia areata).

Scarring alopecias

Lichen planopilaris, frontal fibrosing alopecia and folliculitis decalvans destroy the follicle and replace it with scar. The inflammation must be shown to be inactive for a sustained period before any graft is placed, and some of these conditions are known to flare in response to surgical trauma. A clinic that grafts a frontal fibrosing hairline without a biopsy and a period of documented quiescence is doing something indefensible.

Active infection or inflammation

Folliculitis, an untreated fungal infection, or a scalp in the middle of a flare of seborrhoeic dermatitis or psoriasis all postpone surgery rather than cancel it. Treat the scalp, then reassess. This is a wait, not a refusal.

Expectations that no surgical result will satisfy

Two versions come up often. The first is the fixed image: a photograph from school, a teenage hairline, a density the donor supply cannot fund. That is usually solvable by an honest conversation, drawings on the actual scalp, and a clear statement of what the outcome will and will not look like at ten to twelve months.

The second is harder. Where distress is disproportionate to the visible loss, or the hair has become the explanation for problems that sit elsewhere in a life, surgery reliably fails to help. Body dysmorphic concerns are a recognised reason to decline cosmetic surgery of any kind, and the response is a referral rather than a scalpel. Any clinic promising a result will fix how you feel has stopped practising medicine, which is also why guarantees and quoted success rates should raise your guard.

What should be offered instead of surgery

A decline that ends the conversation is a poor decline. Each of the situations above has a next step, and a clinic that has genuinely assessed you can name yours.

Finding	Reasonable next step
Donor miniaturisation (DUPA)	Medical therapy, cosmetic options, scalp micropigmentation
Rapid loss under 25	Medical therapy, fixed photographs, review in 6–12 months
Diffuse thinning, no pattern	Full workup, medical therapy, styling and concealers
Thyroid or iron abnormality	Correct the cause, then reassess the hair
Active areata or scarring alopecia	Dermatology treatment, quiescence documented first
Expectation mismatch	Second consultation, or referral where appropriate

Medical and in-clinic options overlap here. Platelet-rich plasma helps only where there is still hair to support, which is a different question from whether it substitutes for surgery — the comparison between PRP and a transplant covers where each fits. For loss that is still active, a structured hair fall assessment is where the useful work happens.

What a responsible no sounds like

You should be able to leave with four things: the finding, the reasoning, the alternative, and the review point. Something closer to "your donor density measures below what this plan needs, so grafting now would thin the back without covering the front; here is what we would do instead, and here is when we would look again".

What it should not sound like is a smaller package, a discount for booking today, or a suggestion that the concern would disappear with a different technique. Technique does not fix an unsuitable donor area. Neither follicular unit extraction nor direct hair implantation changes how much hair exists on your head.

A clinic that has never declined anyone is not unusually skilled. It is answering a different question from the one you asked.

Getting a second opinion, and what to take

If you have been declined and want another view, that is reasonable. If you were accepted within ten minutes, a second opinion is arguably more valuable. Take the following:

• Photographs of your scalp from several years ago, and recent ones taken at fixed angles in the same light.
• Any blood results you already have, with dates, plus a full list of medications and supplements.
• Written findings from the first clinic, including donor density if it was measured.
• The specific reason you were declined, in the clinic's own words.

Then ask the second clinic to examine the donor area under magnification and tell you what they measure. The questions worth asking at a consultation are largely about what was measured and who does the work — the law on who may operate in India is clearer than most patients expect.

Cost should not be introduced into a suitability decision at all; it belongs on the page explaining how graft numbers and cost relate. Suitability is a clinical judgement made by the doctor who would perform the procedure, after examination, and it is the one part of this process that should never be negotiable.